Press Release

Jul 26, 2022
Launch of First Direct to Consumer Social Media Awareness Campaign for the Alzheimer’s Risk Test

For many people, the desire to learn more about the risk of developing Alzheimer’s disease stems from seeing a relative with the condition, while for others there is concern that a loved one may be exhibiting symptoms or a wish to be proactive about their long-term health. A new multi-channel campaign aims to make consumers aware that not only is it possible to assess each person’s individual risk but there are ways to prevent or take control of their well-being. Using social media and Google tools, the campaign is reaching millions of US consumers around the network of clinics that are offering the Alzheimer’s Risk Test, powered by genoSCORE™. As well as being educational and informative, the campaign enables anyone interested in receiving the test to be directed to their nearest clinic. Since its launch, over 500 consumers have been connected to a healthcare professional who can help answer their questions and provide reassurance and guidance.

About Cytox (www.cytoxgroup.com)
Cytox Limited aims to enable everyone to know their personal risk for Alzheimer’s disease. Cytox supports two products in the market, powered by its genoSCORE™ Polygenic Risk Scoring technology. In the US, Cytox has partnered with Sampled Smart Labs which has developed the Alzheimer’s Risk Test, powered by genoSCORE™ (www.alzheimers-risk-test.com). In Europe Cytox, with its partner Yourgene Health, markets genoSCORE™-LAB (www.genoscore-lab.com).

About genoSCORE™
The genoSCORE™ technology is used to assess the genetic risk of cognitive decline due to Alzheimer’s disease (AD). The test, which uses a simple blood or saliva sample, analyses over 100,000 single nucleotide polymorphisms (SNPs) - small genetic variations - that are associated with AD. As such, the test generates a patient-specific polygenic risk score (PRS). Clinicians can use the test to assess patients for the risk of developing Alzheimer's, including before symptoms arise. In addition, the test can be used by developers of new AD drugs to identify individuals most likely to experience cognitive decline and/or respond to the therapy under investigation.

About Sampled and Sampled SMART Labs
Sampled is a next-generation laboratory that unlocks the valuable data in any biological sample to enable health innovators to improve human health. The integrated services offered by Sampled SMART Labs provide partners with a seamless solution for sample management and analysis. Sampled is headquartered in Piscataway, N.J. with labs across the US and Europe and partner labs in the Netherlands, China, and Australia. Infinity BiologiX LLC, Roylance Stability Storage Limited, and Roylance Scientific Limited are doing business as Sampled. For more information, visit www.sampled.com.

About Yourgene Health
Yourgene Health is an international molecular diagnostics group which develops integrated genomic technologies and services enabling precision medicine. The group works in partnership with global leaders in DNA technology to advance diagnostic science. Yourgene Health is headquartered in Manchester, UK with offices in Taipei, Singapore, the US, and Canada, and is listed on the London Stock Exchange's AIM market under the ticker "YGEN". For more information visit www.yourgene-health.com.